Canada-anchored operations, with cross-border activity into the United States where regulated frameworks permit. Strong base in Atlantic Canada with national reach.
- Canada
- United States
Greenbridge maintains active partners across North America, Europe, the UK, Asia-Pacific, Latin America, the Middle East, and Africa, with execution experience in 16 countries.
Canada-anchored operations, with cross-border activity into the United States where regulated frameworks permit. Strong base in Atlantic Canada with national reach.
Focus on Germany, France, and the broader EU regulated medical cannabis market. Active in GACP-to-EU-GMP supply pipelines, processor alignment, and pharmacy distribution.
Pharmacy and clinic channel access, import-readiness support, and supplier qualification for UK private prescription markets.
Australia, New Zealand, and Thailand medical cannabis market support, including supplier qualification, import coordination, and distributor introductions.
Engagement with regulated cultivation and export programs in Latin America, including GACP-aligned supply and cross-border qualification support.
Engagement with Israel's mature medical cannabis framework, including IMC-GAP/IMC-GMP qualified cultivators, processors, and export partners.
Support for South African cultivators and exporters targeting EU and other regulated medical cannabis markets.
The core of Greenbridge's network and execution capability. Cultivation, processing, packaging, distribution, and pharmacy channels across GACP, GMP, and EU-GMP standards.
Select engagements in other regulated product categories where Greenbridge's qualification, documentation, and supply-chain coordination capabilities translate.
Greenbridge tracks emerging regulated markets in advance of operator readiness, including jurisdictions in early licensing stages.
Tell us where you are going and what you are bringing or seeking.